Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
Latest Stories